Important note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
|
|
San Francisco Chronicle (12.21.04) - Tuesday, December 21, 2004
Sabin Russell
LGV - a form of chlamydia rarely seen outside of poor, tropical nations - can cause genital and colon scarring, and can produce a swelling and rupturing of lymph glands near the groin. Rotterdam doctors reported 92 cases among gay men during a 17-month period ending in September. Isolated cases have also been reported in Belgium, France, Sweden and Atlanta.
In November, San Francisco City Clinic doctors treated one man with LGV, and subsequent testing of more than 100 previously stored rectal chlamydia specimens from patients turned up three more LGV cases. None of the infected patients had visited the Netherlands, so there may be other people with undiagnosed LGV in the city, said Dr. Sam Mitchell, a Department of Public Health epidemiologist.
Some LGV-infected San Francisco patients also had HIV. While there is no sign HIV-positive patients are at higher risk for LGV-related complications, patients might be more likely to contract HIV because of the ulcerations caused by LGV, said Mitchell.
Because early LGV infections are difficult to distinguish, officials recommend treating all rectal chlamydia cases with the three-week course of antibiotics used to successfully treat LGV. A single dose is usually required for more common chlamydia strains. "The idea is to knock it out quickly. If it circulates widely, it could be quite challenging," said Mitchell. "We think doctors should err on the side of caution."
041221
AD042598
Copyright © 2004 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.